WEST PHARMACEUTICAL SERVICES (WST) Stock Analyst Earnings Estimates
NYSE:WST - New York Stock Exchange, Inc. - US9553061055 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.887B 1.95% | 2.95B 2.18% | 2.893B -1.92% | 3.058B 5.70% | 3.243B 6.05% | 3.454B 6.51% | 3.74B 8.28% | 4.004B 7.06% | 4.3B 7.39% | |
| EBITDA YoY % growth | 875.5M -0.45% | 842.4M -3.78% | 744.9M -11.57% | 744.6M -0.04% | 836.96M 12.40% | 924.52M 10.46% | 1.042B 12.71% | 1.14B 9.40% | N/A | |
| EBIT YoY % growth | 754.9M -0.30% | 705.1M -6.60% | 589.5M -16.39% | 576.16M -2.26% | 656.76M 13.99% | 741.9M 12.96% | 840.12M 13.24% | 914.2M 8.82% | 1.133B 23.93% | |
| Operating Margin | 26.15% | 23.90% | 20.38% | 18.84% | 20.25% | 21.48% | 22.46% | 22.83% | 26.35% | |
| EPS YoY % growth | 8.57 -0.46% | 8.08 -5.72% | 6.75 -16.46% | 6.34 -6.10% | 7.18 13.21% | 8.35 16.40% | 9.65 15.55% | 10.55 9.37% | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.70 -8.21% | 1.79 -1.51% | 1.56 7.41% | 1.75 -5.15% | 1.83 7.66% | 1.97 9.87% | 1.46 -5.97% | 1.74 -0.46% | 1.90 3.87% | 2.16 9.74% |
| Revenue Q2Q % growth | 790.6M 5.85% | 800.4M 6.89% | 751.9M 7.72% | 787.99M 2.80% | 794.08M 0.44% | 813.13M 1.59% | 750.38M -0.20% | 784.31M -0.47% | 792.95M -0.14% | 838.31M 3.10% |
| EBITDA Q2Q % growth | 192.08M -31.06% | 201.78M -37.59% | 179.84M 8.14% | 204.16M -14.65% | 209.39M 9.01% | 223.18M 10.61% | 174.15M -3.16% | 198.57M -2.74% | 212.88M 1.67% | 235.85M 5.68% |
| EBIT Q2Q % growth | 147.89M -9.77% | 157.05M -6.46% | 136.45M 8.04% | 151.02M -4.30% | 160.73M 8.68% | 174.04M 10.82% | 129.77M -4.90% | 153.97M 1.95% | 168.31M 4.72% | 192.18M 10.42% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.84 21.05% | 1.52 | 0.32 | 20.68% |
| Q1 2025 Q2Q % growth | 1.45 -7.05% | 1.25 | 0.20 | 16.40% |
| Q4 2024 Q2Q % growth | 1.82 -0.55% | 1.74 | 0.08 | 4.78% |
| Q3 2024 Q2Q % growth | 1.85 -14.35% | 1.52 | 0.33 | 22.11% |
| Q2 2024 Q2Q % growth | 1.52 -27.96% | 1.76 | -0.24 | -13.56% |
| Q1 2024 Q2Q % growth | 1.56 -21.21% | 1.29 | 0.27 | 21.26% |
| Q4 2023 Q2Q % growth | 1.83 3.39% | 1.80 | 0.03 | 1.93% |
| Q3 2023 Q2Q % growth | 2.16 6.40% | 1.87 | 0.29 | 15.21% |
| Q2 2023 Q2Q % growth | 2.11 -14.57% | 1.95 | 0.16 | 8.45% |
| Q1 2023 Q2Q % growth | 1.98 -13.91% | 1.69 | 0.29 | 17.48% |
| Q4 2022 Q2Q % growth | 1.77 -13.24% | 1.39 | 0.38 | 27.34% |
| Q3 2022 Q2Q % growth | 2.03 -1.46% | 2.14 | -0.11 | -5.19% |
| Q2 2022 Q2Q % growth | 2.47 0.41% | 2.24 | 0.23 | 10.49% |
| Q1 2022 Q2Q % growth | 2.30 12.20% | 2.14 | 0.16 | 7.25% |
| Q4 2021 Q2Q % growth | 2.04 52.24% | 1.93 | 0.11 | 5.47% |
| Q3 2021 Q2Q % growth | 2.06 79.13% | 1.81 | 0.25 | 13.52% |
| Q2 2021 Q2Q % growth | 2.46 96.80% | 1.76 | 0.70 | 39.98% |
| Q1 2021 Q2Q % growth | 2.05 102.97% | 1.45 | 0.60 | 41.77% |
| Q4 2020 Q2Q % growth | 1.34 63.41% | 1.14 | 0.20 | 17.93% |
| Q3 2020 Q2Q % growth | 1.15 45.57% | 1.01 | 0.14 | 14.15% |
| Q2 2020 Q2Q % growth | 1.25 40.45% | 0.92 | 0.33 | 36.38% |
| Q1 2020 Q2Q % growth | 1.01 36.49% | 0.83 | 0.18 | 21.65% |
| Q4 2019 Q2Q % growth | 0.82 | 0.73 | 0.09 | 12.45% |
| Q3 2019 Q2Q % growth | 0.79 | 0.72 | 0.07 | 10.48% |
| Q2 2019 Q2Q % growth | 0.89 | 0.73 | 0.16 | 21.71% |
| Q1 2019 Q2Q % growth | 0.74 | 0.66 | 0.08 | 11.57% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 766.5M 9.17% | 734.72M | 31.78M | 4.33% |
| Q1 2025 Q2Q % growth | 698M 0.37% | 692.7M | 5.3M | 0.77% |
| Q4 2024 Q2Q % growth | 748.8M 2.30% | 747.88M | 920K | 0.12% |
| Q3 2024 Q2Q % growth | 746.9M -0.07% | 716.71M | 30.19M | 4.21% |
| Q2 2024 Q2Q % growth | 702.1M -6.86% | 736.64M | -34.54M | -4.69% |
| Q1 2024 Q2Q % growth | 695.4M -2.96% | 677.32M | 18.08M | 2.67% |
| Q4 2023 Q2Q % growth | 732M 3.29% | 746.86M | -14.86M | -1.99% |
| Q3 2023 Q2Q % growth | 747.4M 8.81% | 757.81M | -10.41M | -1.37% |
| Q2 2023 Q2Q % growth | 753.8M -2.27% | 763.26M | -9.46M | -1.24% |
| Q1 2023 Q2Q % growth | 716.6M -0.47% | 705.17M | 11.43M | 1.62% |
| Q4 2022 Q2Q % growth | 708.7M -3.02% | 663.74M | 44.96M | 6.77% |
| Q3 2022 Q2Q % growth | 686.9M -2.77% | 738.23M | -51.33M | -6.95% |
| Q2 2022 Q2Q % growth | 771.3M 6.59% | 764.77M | 6.53M | 0.85% |
| Q1 2022 Q2Q % growth | 720M 7.35% | 728.13M | -8.13M | -1.12% |
| Q4 2021 Q2Q % growth | 730.8M 25.96% | 717.3M | 13.5M | 1.88% |
| Q3 2021 Q2Q % growth | 706.5M 28.92% | 693.96M | 12.54M | 1.81% |
| Q2 2021 Q2Q % growth | 723.6M 37.25% | 676.08M | 47.52M | 7.03% |
| Q1 2021 Q2Q % growth | 670.7M 36.46% | 617.51M | 53.19M | 8.61% |
| Q4 2020 Q2Q % growth | 580.2M 23.29% | 549.11M | 31.09M | 5.66% |
| Q3 2020 Q2Q % growth | 548M 20.15% | 515.25M | 32.75M | 6.36% |
| Q2 2020 Q2Q % growth | 527.2M 12.24% | 501.05M | 26.15M | 5.22% |
| Q1 2020 Q2Q % growth | 491.5M 10.82% | 471.46M | 20.04M | 4.25% |
| Q4 2019 Q2Q % growth | 470.6M | 456.04M | 14.56M | 3.19% |
| Q3 2019 Q2Q % growth | 456.1M | 455.45M | 650K | 0.14% |
| Q2 2019 Q2Q % growth | 469.7M | 465.01M | 4.69M | 1.01% |
| Q1 2019 Q2Q % growth | 443.5M | 434.4M | 9.1M | 2.09% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 4.43% | 3.53% | 0% | -0.31% |
| Revenue | 3.5% | 6.06% | 2.24% | 2.24% |